Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies

Blood

Volumn 82, Issue 6, 1993, Pages 1803-1812

  Bohlen, H ^a   Hopff, T ^a   Manzke, O ^a   Engert, A ^a   Kube, D ^a   Wickramanayake, P D ^a   Diehl, V ^a   Tesch, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MONOCLONAL ANTIBODY; OKT 3; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER IMMUNOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HYBRIDOMA; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR CELL DESTRUCTION;

EID: 0027281795     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v82.6.1803.bloodjournal8261803     Document Type: Article

References (0)